As his father battled blood cancer, Keith Morgan, EG21, felt… intrigued. Well, he felt scared, first and foremost. Morgan’s beloved dad had been a formidable lieutenant colonel in the U.S. Army, and ...
Fueled by generous philanthropic support and insights from industry partners, the University of Delaware launched a new master’s program in biopharmaceutical sciences in June. AstraZeneca, Bristol ...
SHANGHAI, Feb. 10, 2026 /PRNewswire/ -- AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms spanning the full ...
The quality of a drug product is determined by the manufacturing line. Preclinical assessments and clinical trials provide an indication of safety and efficacy, but it is the manufacturing process ...
Huawu Biopharmaceutical Technology (Hubei) Co. Ltd. has divulged new viral replication inhibitors potentially useful for the treatment of dengue and yellow fever virus infections.
Yokogawa announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess software and services. Fostering the ...
The biopharmaceutical field leads the way in science, researching and developing new treatments for health needs. In 2024, research and development in this area will face fast changes, bringing both ...
A bipartisan group of senators and representatives introduced legislation to establish a National Biopharmaceutical Manufacturing Center of Excellence (COE), inspired by recommendations from the ...
No articles found. Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd. did not contribute to any primary research papers from Nature Index journals in the current 12 month window.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results